<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Partial gains of chromosome 1q as isolated aberrations are rare occurrences in <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>A recent report of a sole duplication dup(1)(q21q32) in <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) suggested an inferior prognosis </plain></SENT>
<SENT sid="2" pm="."><plain>To further describe structural anomalies involving the 1q21 and 1q32 breakpoints, we present four cases with an inverted dup(1)(q32q21): three in B-cell precursor <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (ALL) and one in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> of the subtype refractory cytopenia with multilineage <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and ringed sideroblasts </plain></SENT>
<SENT sid="3" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> four cases, the aberration presented as the sole anomaly at diagnosis </plain></SENT>
<SENT sid="4" pm="."><plain>In one of the ALL cases, relapse during chemotherapy, 5 months from diagnosis, was accompanied by <z:e sem="disease" ids="C1516669" disease_type="Neoplastic Process" abbrv="">clonal evolution</z:e>; in another ALL case, early relapse appeared 51 days after allogeneic stem cell transplantation </plain></SENT>
<SENT sid="5" pm="."><plain>Structural gains of 1q involving 1q32 and 1q21 breakpoints can occur in different <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematological malignancies</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>The isolated occurrence of the inverted dup(1)(q32q21) may be interpreted as a typical primary alteration in B-lineage ALL paving the way to acquisition of additional abnormalities </plain></SENT>
<SENT sid="7" pm="."><plain>Identification of more cases could further clarify the role of 1q duplications with the q21 and q32 breakpoints in <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematological malignancies</z:e> and better define the prognosis associated with sole aberration in the single entities </plain></SENT>
</text></document>